Alejandro Lemor MD, MS
@AlejandroLemor
Followers
1K
Following
2K
Media
59
Statuses
330
Interventional Cardiologist @UMMC_heart | @HenryFordHealth & @MountSinaiNYC alumni | Researcher #ComplexPCI #MCS #CardiogenicShock | 🇵🇪
Joined May 2011
It was great to have Dr Karthik Ananth (@HenryFordHealth ) for @UMMCMedicine Grand Rounds and update us all on "Cardiovascular PET Imaging”.
0
2
9
📖PVAD-supported high-risk #PCI in non-shock patients may be associated with improved clinical out-comes compared with #IABP support 💡Read more ⤵️ ➡️ https://t.co/JdYtS6kRM0
@AlexandraLansky @TayyabShahMD @JWMoses @AlejandroLemor @BillONeillMD
1
2
5
Very important work led by @JasmineMarquard & Danger Investigators w/ improved outcomes observed w/ MV-PCI compared to culprit vessel PCI (hypothesis generating), similar to what @AlejandroLemor showed in #NCSI. Very low rate of CTO PCI (6%), all STEMI, no comatose OHCA
3
16
53
Department of Medicine Grand Rounds Tuesday, September 30th at noon, Dr. Alejandro Lemor will present "Contemporary Management of Cardiogenic Shock" in R354 and WebEx https://t.co/tGZJvA00BS
0
2
2
🚨 New Findings from PROTECT III: focused on pt baseline characteristics & short- intermediate outcomes when treated with #Impella-supported #HRPCI. ➡️ https://t.co/bNVW1UqSa0
@FalahBatla @TayyabShahMD @abu_much @djc795 @BjornRedfors @SuzanneJBaron @Babar_Basir @adityadoc1
0
5
12
When patients were stratified into 2 cohorts based on HRPCI score (scores 0–4 vs. scores 5–8) 30-day mortality was significantly higher among those with scores 5–8 (5.4 % vs. 17.0 %, HR [95 % CI] = 3.4 [2.12–5.51], p < 0.0001)
1
0
6
🚫Limitation: only for patients undergoing HRPCI with Impella (Protect III database). The score needs further external validation.
1
0
4
Novel risk score for Impella-HRPCI to calculate in-hospital mortality. Easy to remember and can be useful to discuss risk of mortality with patients undergoing #HRPCI. 📌 https://t.co/8zLGuDIQ2Q
6
28
89
Wonderful work led by @ImranAziz96 @AhmadJabri8 & YingXu on flow characteristics of reperfusion sheaths w large bore MCS. No difference b/t sheath sizes (as it relates to flow), better flow w active flow vs passive. Need detected sheaths in the future. https://t.co/oQBxY4gUfr
3
13
44
Save the date! 🗓️ Join us for the Cardiogenic Shock LATAM Symposium 🫀⚡️in beautiful Cancun! An unmissable event for experts and innovators in the field. Stay tuned for more details! #CShockLATAM @TecSaludMX @GTorreAmione
0
5
21
📘#SCAIMCSebook Highlight: Chapter 7—Treatment Escalation Guidelines. Early intervention is critical and knowing when to escalate MCS starts with identifying worsening or undertreated #CardiogenicShock. This chapter explores escalation options, key parameters for deteriorating
0
4
6
Discover the foundations of #CardiogenicShock and #MCS with SCAI's newest ebook, “Short-Term Mechanical Circulatory Support for Cardiogenic Shock” 📘➡️ https://t.co/b0MfjVhBvo 📖 Section 1 dives into critical topics, including understanding #CS, the use of right heart
0
13
34
More “why-when MCS” for high-risk PCI: “Clinical Outcomes of Patients Experiencing Transient Loss of Pulse Pressure During High-Risk PCI with Impella”👉: 🔗 https://t.co/6K3pqMorMY…
1
8
26
Have you ever wondered if LOPP during HR-PCI meant anything? Interesting 1/2 of HR-PCI pts supported w/ Impella experienced LOPP. It was not benign! LOPP was associated w/ increased rates of MACCE. More to come in the Protect IV trial. @GreggWStone @duanepinto @JWMoses
6
20
77
Very important work on RVD in NCSI led by @SarahGorgis @krtkgpt @AlejandroLemor. RVD (defined as RA > 12, PAPI <1) was present in about ~30% of AMI-CS pts. Pts w RVD were sicker, had higher SCAI shock stage, lactate & worse mortality. @JCardFail
https://t.co/vEYoEXDReY
1
20
57
Check out the #SCAISHOCK 2024 preliminary program for a first look at some of the sessions you can attend during the conference this October 17-19 ➡️ https://t.co/RAmQYgmwrA 📌Register now to join us in Washington, DC: https://t.co/KANqt3qdnf
#CardiogenicShock #Shock
0
3
15
Case submission is open for SCAI Shock! Best saves, worst complications, interesting hemodynamics we want it all! @SCAI @scaielm @Allison_Dupont @SandeepNathanMD @JasonKatzMD @DrRobRoswell @agtruesdell @PerwaizMeraj
The #SCAISHOCK 2024 Call for Cases is OPEN! ⚡ Submit abstracts for the opportunity to share your research and knowledge to improve clinical practices and treatments of #CardiogenicShock. The deadline to submit cases is August 5. ➡️Learn more and submit: https://t.co/Jax69CMvnS
0
18
46
Our analysis of patients with chronic kidney disease (first report of dialysis pts) who received Impella assisted HRPCI in Protect III @CircIntv #CirculationIntv #MedTwitter #CardioTwitter 💥Lower eGFR had more severely calcified CAD, greater atherectomy usage but no increased
11
22
59
Congratulations to a very special group of leaders, many of whom I am privileged to call friends! @AdnanKhalifMD @MichaelMegalyMD @AlejandroLemor @asaadnakhle @AnkurGuptaMD @SarasVallabhMD @kashishgoelmd @HarshGMD @kerrigjl @SMPatelMD @drmeghaprasad @poojaotherwise @KHERA_MD
Celebrating our second class of SCAI's 30 in Their 30s recipients, an annual award that recognizes the accomplishments of early-career interventional cardiologists who have the qualities required to be one of the field's future leaders. #SCAI2024
9
7
41